Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Magnetic Resonance Imaging (MRI) Detection of Iron Overload In Patients with Myelodysplastic Syndrome (MDS),

Fabio P S Santos, MD, Claudia Bley, MD, Ricardo Helman, MD, Guilherme Fleury Perini, MD, Leandro de Padua Silva, MD, Isabel Bello, Carolina Kassab, MD, Breno Pannia Esposito, PhD, Murilo Sergio S. Ribeiro, MD, Cesar Higa Nomura, MD, Fernando Uliana Kay, MD, Ronaldo Hueb Baroni, MD, Elvira RP Velloso, MD, PhD, Nelson Hamerschlak, MD

Blood (2011) 118 (21): 3827.

https://doi.org/10.1182/blood.V118.21.3827.3827

Published: 2011

Journal Articles

Long Term Results of Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome: Analysis of Prognostic Factors

Uday Popat, M.D., Roland Bassett, Leandro de Padua Silva, Amin M Alousi, MD, Paolo Anderlini, MD, Chitra M Hosing, MD, Roy Jones, MD, PhD, Partow Kebriaei, MD, Issa Khouri, MD, Elizabeth J Shpall, MD, Muzaffar H Qazilbash, MD, Guillermo Garcia-Manero, Borje S Andersson, MD, PhD, Richard Champlin, MD, Marcos J de Lima, MD

Blood (2011) 118 (21): 4531.

https://doi.org/10.1182/blood.V118.21.4531.4531

Published: 2011

Journal Articles

Human-Leukocyte-Histocompatibility Antigens Predict Response to Rituximab and Donor Lymphocyte Infusion (DLI) After Non-Myeloablative Allogeneic Stem Transplantation (NST) for Chronic Lymphocytic Leukemia (CLL)

Issa F. Khouri, Roland Bassett, Pedro Cano, Susan O'Brien, Yvonne Hsu, Carlos E. Bueso-Ramos, Robyn Harrell, Grace-Julia Okoroji, Leandro de Padua Silva, Alessandra Ferrajoli, Richard Champlin, John McMannis, Marcelo Fernandez-Vina

Blood (2010) 116 (21): 2548.

https://doi.org/10.1182/blood.V116.21.2548.2548

Published: 2010

Journal Articles

Outcome In Follicular Lymphoma (FL) Patients (pts) Relapsing After Autologous Stem Cell Transplantation (ASCT): Allografting Vs. Conventional Therapy

Grace-Julia Okoroji, Leandro de Padua Silva, Rima M Saliba, Martin Korbling, McLaughlin Peter, Chitra Hosing, Paolo Anderlini, Amin Alousi, Marcos de Lima, Partow Kebriaei, Uday Popat, Muzaffar Qazilbash, Luis Fayad, Felipe Samaniego, MD, MPH, Nathan Fowler, Richard Champlin, Fredrick Hagemeister, Issa F Khouri

Blood (2010) 116 (21): 3510.

https://doi.org/10.1182/blood.V116.21.3510.3510

Published: 2010

Journal Articles

Human-Leukocyte-Histocompatibility Antigens (HLA-A1+, A2-, B44-) and Serum Immunoglobulin (Ig)G with CD4 Levels Predict Response to Graft-Versus-Leukemia (GVL) and Overall Survival, Respectively, After Non-Myeloablative Allogeneic Stem Transplantation (NST) for Chronic Lymphocytic Leukemia (CLL).

Issa F Khouri, Roland L Bassett, Jr., Pedro Cano, Susan O'Brien, Yvonne Hsu, Carlos E Bueso-Ramos, Robyn Harrell, Grace-Julia Okoroji, Leandro De Padua Silva, Alessandra Ferrajoli, William Wierda, Hagop Kantarjian, Richard Champlin, John McMannis, Marcelo Fernandez-Vina

Blood (2009) 114 (22): 2287.

https://doi.org/10.1182/blood.V114.22.2287.2287

Published: 2009

Journal Articles

Rapid Engraftment of Neutrophils and Platelets with Mesenchymal Stem Cell Based Cord Blood (CB) Expansion (EXP).

Blood (2009) 114 (22): 3394.

https://doi.org/10.1182/blood.V114.22.3394.3394

Published: 2009

Journal Articles

Co-Morbidity Score at the Time of Transplant Determines Prognosis in Older Patients Who Develop Acute Graft-Vs.-Host Disease (GVHD).

Amin M Alousi, Gabriela Rondon, Grace-Julia Okoroji, Uday Popat, Leandro De Padua Silva, Sharon Hymes, Joyce Neumann, Nicole M Brunelle, Partow Kebriaei, Chitra Hosing, Issa F Khouri, Elizabeth J Shpall, Muzaffar H Qazilbash, Sergio Giralt, Richard Champlin, Rima M Saliba

Blood (2009) 114 (22): 2244.

https://doi.org/10.1182/blood.V114.22.2244.2244

Published: 2009

Journal Articles

Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease

Simrit Parmar, Marcos del Lima, Yizhou Zou, Poliana A. Patah, Ping Liu, Pedro Cano, Gabriela Rondon, Susana Pesoa, Leandro de Padua Silva, Muzaffar H. Qazilbash, Chitra Hosing, Uday Popat, Partow Kebriaei, Elizabeth J. Shpall, Sergio Giralt, Richard E. Champlin, Peter Stastny, Marcelo Fernandez-Vina

Blood (2009) 114 (14): 2884–2887.

https://doi.org/10.1182/blood-2009-05-223172

Published: 2009

Includes: Supplemental data

Journal Articles

Results of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Advanced Chronic Myeloid Leukemia (CML) Patients (pts) Who Failed Tyrosine Kinase Inhibitors (TKIs) after Developing BCR-ABL Kinase Domain (KD) Mutations.

Elias Jabbour, Jorge Cortes, Leandro de Padua Silva, Marcos De Lima, Dan Jones, Susan O’Brien, Gabriela Rondon, Uday Popat, Sergio Giralt, Hagop Kantarjian, Richard Champlin

Blood (2008) 112 (11): 973.

https://doi.org/10.1182/blood.V112.11.973.973

Published: 2008

Journal Articles

Treatment of AML in First Remission (CR1) with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Using Unrelated Donors (UD).

Leandro de Padua Silva, Borje S. Andersson, Uday Popat, Lori Griffin, Michele Alvarez, Poliana Patah, Simrit Parmar, Sergio Giralt, Gabriela Rondon, Marcelo Fernandez-Vina, Pedro Cano, Richard E. Champlin, Marcos De Lima

Blood (2008) 112 (11): 976.

https://doi.org/10.1182/blood.V112.11.976.976

Published: 2008

Journal Articles

Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients (pts) with Advanced Chronic Myeloid Leukemia (CML) Post Imatinib Failure.

Elias Jabbour, Marcos De Lima, Leandro de Padua Silva, Sergio Giralt, Jorge Cortes, Muzaffar Qazilbash, Gabriela Rondon, Stefan Ciurea, Roy Jones, Yago Nieto, Martin Korbling, Daniel Couriel, Hagop Kantarjian, Richard Champlin

Blood (2008) 112 (11): 979.

https://doi.org/10.1182/blood.V112.11.979.979

Published: 2008

Journal Articles

Busulfan and Fludarabine Conditioning Regimen Negates the Impact of Comorbidity Score on Nonrelapse Mortality in Patients with AML/MDS

Uday Popat, MD, Rima Saliba, PhD, Leandro de Padua Silva, MD, Borje S Andersson, MD, PhD, Amin M Alousi, MD, Paolo Anderlini, MD, Marcos de Lima, MD, Grace-Julia Okoroji, MS, BS, Chitra M Hosing, MD, Roy B Jones, MD, PhD, Partow Kebriaei, MD, Issa Khouri, MD, Yago Nieto, MD, PhD, Muzaffar H Qazilbash, MD, Richard Champlin, MD, Sergio A Giralt, MD

Blood (2008) 112 (11): 799.

https://doi.org/10.1182/blood.V112.11.799.799

Published: 2008

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Versus Conventional Chemotherapy in Patients with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) Attaining Complete Remission (CR1) Post Induction Chemotherapy: a Retrospective Case Control Study.

Yvonne A Efebera, MD, Hagop M. Kantarjian, MD, Borje Andersson, MD, Sherry Pierce, Leandro De Padua Silva, MD, Farhad Ravandi, MD, Sergio A. Giralt, MD, Gautam Borthakur, MD, Richard Champlin, MD, Marcos De Lima, MD

Blood (2008) 112 (11): 1125.

https://doi.org/10.1182/blood.V112.11.1125.1125

Published: 2008

Journal Articles

Prognostic Factors after Nonmyeloablative Allogeneic Stem Transplantation (NST) in Chronic Lymphocytic Leukemia (CLL): Expression of P53 May Not Predict Survival.

Issa Khouri, Roland L Bassett, Yvonne Hsu, Timothy Dickason, Sandra Acholonu, Robyn Harrell, Grace-Julia Okoroji, Leandro de Padua Silva, Martin J. Korbling, Amin M. Alousi, Chitra Hosing, Uday Popat, Sergio A. Giralt, Partow Kebriaei, Muzaffar H. Qazilbash, M.D., Celina Ledesma, Michael J. Keating, MB, BS, Richard E. Champlin, Carlos Bueso-Ramos

Blood (2008) 112 (11): 1128.

https://doi.org/10.1182/blood.V112.11.1128.1128

Published: 2008

Journal Articles

Allogeneic Transplantation (HCT) for Myelodysplastic Syndrome:Recent MDACC Experience.

Uday Popat, MD, Marcos J de Lima, MD, Touch Ativitavas, MD, Gabriela Rondon, MD, Leandro de Padua Silva, MD, Ebru Koca, MD, Weiqing Zhang, MD, Amin Alousi, MD, Paolo Anderlini, MD, Sergio A. Giralt, MD, Chitra M. Hosing, MD, Roy Jones, MD, PhD, Partow Kebriaei, MD, Issa Khouri, MD, Yago Nieto, MD, PhD, Muzaffar H. Qazilbash, MD, Borje S. Andersson, MD, PhD, Richard Champlin, MD

Blood (2008) 112 (11): 1131.

https://doi.org/10.1182/blood.V112.11.1131.1131

Published: 2008

Journal Articles

Maintenance Therapy with Low-Dose Azacitidine (AZA) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed or Refractory AML or MDS: A Dose and Schedule Finding Study.

Marcos De Lima, Leandro de Padua Silva, Sergio Giralt, Krishna Komanduri, Borje S. Andersson, Chitra Hosing, Muzaffar Qazilbash, Elizabeth Shpall, Peter Thall, Weiqing Zhang, Gloria McCormick, Xuemei Wang, Uday Popat, Andres Soriano, Amin Alousi, Richard Champlin, Guillermo Garcia-Manero

Blood (2008) 112 (11): 1134.

https://doi.org/10.1182/blood.V112.11.1134.1134

Published: 2008

Journal Articles

Addition of Rituximab to Mobilization and Conditioning Overcomes the Predictive Value of Follicular Lymphoma International Prognostic Index (FLIPI) Score in Patients with Relapsed FL Undergoing Autologous Stem Cell Transplantation (AUTO).

Issa F Khouri, M.D., Roland Bassett, Barry Samuels, Farzaneh Maadani, Grace-Julia Okoroji, Robyn Harrell, Martin Korbling, Leandro de Padua Silva, Amin Alousi, Chitra Hosing, Sergio Giralt, Marcos de Lima, Paolo Anderlini, Uday Popat, Rosamar Valverde, Yvonne Hsu, Fredrick Hagemeister, Peter McLaughlin, L. Jeffrey Medeiros

Blood (2008) 112 (11): 1140.

https://doi.org/10.1182/blood.V112.11.1140.1140

Published: 2008

Journal Articles

Myeloablative Chemotherapy for T-Cell Lymphoma: a Case for Autologous Stem Cell Transplantatin (Auto) in First Remission.

Issa F Khouri, Adriana Lopez, Grace-Julia Okoroji, Martin Korbling, MD, Gloria McCormick, Yvonne Hsu, Leandro de Padua, Amin M. Alousi, Chitra M. Hosing, Partow Kebriaei, MD, Gabriela Rondon, Sergio A Giralt, MD, Marcos J. de Lima, Paolo Anderlini, Uday R Popat, Muzaffar H. Qazilbash, Richard E. Champlin, Barbara Pro

Blood (2008) 112 (11): 1141.

https://doi.org/10.1182/blood.V112.11.1141.1141

Published: 2008

Journal Articles

Rituximab Containing Autologous Stem Cell Transplantation May Be Curative in Mantle Cell Lymphoma for Patients in First Remission, but Not for Patients with Recurrent Disease.

Blood (2008) 112 (11): 1142.

https://doi.org/10.1182/blood.V112.11.1142.1142

Published: 2008

Journal Articles

Myeloablative, Reduced Toxicity IV Busulfan/Fludarabine (BuFlu) and Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Patients in the 6th and 7th Decades of Life with AML or MDS

Gheath Alatrash, Borje S. Andersson, Matteo Pelosini, Gabrila Rondon, Muzaffar H. Qazilbash, Sergio Giralt, Leandro de Padua Silva, Chitra Hosing, Partow Kebriaei, Weiqing Zhang, Rima Saliba, Richard E. Champlin, Marcos De Lima

Blood (2008) 112 (11): 2999.

https://doi.org/10.1182/blood.V112.11.2999.2999

Published: 2008

NARROW

Magnetic Resonance Imaging (MRI) Detection of Iron Overload In Patients with Myelodysplastic Syndrome (MDS),

Long Term Results of Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome: Analysis of Prognostic Factors

Human-Leukocyte-Histocompatibility Antigens Predict Response to Rituximab and Donor Lymphocyte Infusion (DLI) After Non-Myeloablative Allogeneic Stem Transplantation (NST) for Chronic Lymphocytic Leukemia (CLL)

Outcome In Follicular Lymphoma (FL) Patients (pts) Relapsing After Autologous Stem Cell Transplantation (ASCT): Allografting Vs. Conventional Therapy

Human-Leukocyte-Histocompatibility Antigens (HLA-A1+, A2-, B44-) and Serum Immunoglobulin (Ig)G with CD4 Levels Predict Response to Graft-Versus-Leukemia (GVL) and Overall Survival, Respectively, After Non-Myeloablative Allogeneic Stem Transplantation (NST) for Chronic Lymphocytic Leukemia (CLL).

Rapid Engraftment of Neutrophils and Platelets with Mesenchymal Stem Cell Based Cord Blood (CB) Expansion (EXP).

Co-Morbidity Score at the Time of Transplant Determines Prognosis in Older Patients Who Develop Acute Graft-Vs.-Host Disease (GVHD).

Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease

Results of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Advanced Chronic Myeloid Leukemia (CML) Patients (pts) Who Failed Tyrosine Kinase Inhibitors (TKIs) after Developing BCR-ABL Kinase Domain (KD) Mutations.

Treatment of AML in First Remission (CR1) with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Using Unrelated Donors (UD).

Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients (pts) with Advanced Chronic Myeloid Leukemia (CML) Post Imatinib Failure.

Busulfan and Fludarabine Conditioning Regimen Negates the Impact of Comorbidity Score on Nonrelapse Mortality in Patients with AML/MDS

Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Versus Conventional Chemotherapy in Patients with Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) Attaining Complete Remission (CR1) Post Induction Chemotherapy: a Retrospective Case Control Study.

Prognostic Factors after Nonmyeloablative Allogeneic Stem Transplantation (NST) in Chronic Lymphocytic Leukemia (CLL): Expression of P53 May Not Predict Survival.

Allogeneic Transplantation (HCT) for Myelodysplastic Syndrome:Recent MDACC Experience.

Maintenance Therapy with Low-Dose Azacitidine (AZA) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed or Refractory AML or MDS: A Dose and Schedule Finding Study.

Addition of Rituximab to Mobilization and Conditioning Overcomes the Predictive Value of Follicular Lymphoma International Prognostic Index (FLIPI) Score in Patients with Relapsed FL Undergoing Autologous Stem Cell Transplantation (AUTO).

Myeloablative Chemotherapy for T-Cell Lymphoma: a Case for Autologous Stem Cell Transplantatin (Auto) in First Remission.

Rituximab Containing Autologous Stem Cell Transplantation May Be Curative in Mantle Cell Lymphoma for Patients in First Remission, but Not for Patients with Recurrent Disease.

Myeloablative, Reduced Toxicity IV Busulfan/Fludarabine (BuFlu) and Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Patients in the 6th and 7th Decades of Life with AML or MDS

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only